Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Issuance of Common Stock

Apellis Pharmaceuticals Inc Issuance of Common Stock Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Issuance of Common Stock from 2017 to 2018.
  • Apellis Pharmaceuticals Inc Issuance of Common Stock for the quarter ending December 12, 2018 was $0m a -135,061.39% decrease of -150m year over year
  • Apellis Pharmaceuticals Inc Issuance of Common Stock for the last 12 months ending December 12, 2018 was $132m a -14.44% decrease of -19m year over year
  • Apellis Pharmaceuticals Inc Annual Issuance of Common Stock for 2018 was $132m a -14.27% decrease of -19m from 2017
  • Apellis Pharmaceuticals Inc Annual Issuance of Common Stock for 2017 was $151m a 100.00% increase of 151m from 2016
  • Apellis Pharmaceuticals Inc Annual Issuance of Common Stock for 2015 was $0m
Other Cash Flow Metrics:
  • Apellis Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-44m a 48.43% decrease of -22m year over year
  • Apellis Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-39m a 62.21% decrease of -24m year over year
View Chart On Koyfin

Quarterly APLS Issuance of Common Stock Data

12/2018$0m
06/2018$132m
03/2018$0m
12/2017$151m
09/2017$0m

Annual APLS Issuance of Common Stock Data

2018$132m
2017$151m
2015$0m